Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
Marco Caminati, Gabriella Guarnieri, Gianenrico Senna
Abstract
The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...].
Topics & Concepts
Coronavirus disease 2019 (COVID-19)VaccinationMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRegulatory agencyAnaphylaxisAgency (philosophy)CoronavirusVirologyImmunologyAllergyPolitical scienceOutbreakInternal medicinePublic administrationDiseaseInfectious disease (medical specialty)PhilosophyEpistemologyFood Allergy and Anaphylaxis ResearchDrug-Induced Adverse ReactionsVaccine Coverage and Hesitancy